VadasEB.Stability of pharmaceutical products. In: GennaroAR, ed. Remington: The science and practice of pharmacy. 19th ed. Philadelphia: Lippincott Williams & Wilkins, 1995:638–47.
2.
FolbP.Comments on expired medicines (letter) by Barmania A. S Afr Med J1990;78:218.
3.
YorkP.The shelf life of some antibiotic preparations stored under tropical conditions. Pharmazie1977;32:101–4.
4.
KumarS.India's heat wave and rains result in massive death toll. Lancet1998;351:1869.
5.
AryaSC.Global warming and therapeutic agents during travel. J Travel Med1999;6:150–1.
6.
ShakoorOTaylorRBBehernsRH.Assessment of incidence of substandard drugs in developing countries. Trop Med Int Health1997;2:839–45.
7.
BallereauFPrazuckTSchriveILafleurielMTRozecDFischAStability of essential drugs in the field: Results of a study conducted over a two-year period in Burkina Faso. Am J Trop Med1997;57:31–6.
8.
HogerzeilHVBattersbyASrdanovicVStjernstromNE.Stability of essential drugs during shipment to the tropics. BMJ1992;304:210–2.
9.
Storage and shelf-life of drugs: When is it important?Drug Ther Bull1977;15:81–3.
10.
BerckmansPDawansVSchimetsGVandenberghDAutierP.Inappropriate drug-donation practices in Bosnia and Herzegovina, 1992 to 1996. N Engl J Med1997;337:1842–5.
11.
World Health Organization. The use of essential drugs: Model list of essential drugs: Fifth report of the WHO Expert Committee, 1992. World Health Organ Tech Rep Ser1992;825:1–75.
12.
AutierPFerirMCHairapetienAAlexanianAAgoudjianVSchmetsGDrug supply in the aftermath of the 1988 Armenian earthquake. Lancet1990;335:1388–90.
13.
ZeballosJL.Health aspects of the Mexico earthquake-19 September 1985. Disasters1986;10:141–9.
14.
AliHMHomeidaMMAbdeenMA.“Drug dumping” in donations to Sudan. Lancet1988;1:538–9.
15.
CohenS.Drug donations to Sudan (letter). Lancet1990;336:745.
16.
OfferhausL.Russia: Emergency drugs aid goes awry (letter). Lancet1992;339:607.
A memo on current good manufacturing practice issues on human use pharmaceuticals. Human Drug CGMP Notes1996;4(1):1–13.
19.
21 CFR Parts 210 and 211. Current good manufacturing practice in manufacturing, processing, packing or holding of drugs; general and current good manufacturing practice for finished pharmaceuticals. 21 CFR 211.137(a) and (d), expiration dating; June 30, 2003.